Bharat Biotech’s Nasal Vaccine iNCOVACC To Cost Rs 800: Sources
The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
- Latest
- Trending
The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
Bhubaneswar: Procuring more COVID-19 vaccines is the need of the hour and that can happen only if more and more ...
New Delhi: An expert panel of Drugs Controller General of India (DCGI) has permitted Bharat Biotech to administer a third ...
New Delhi: Having refused permission earlier, the Drugs Controller General of India (DCGI) has now allowed Dr Reddy’s to conduct ...
New Delhi: An indigenous paper-strip COVID-19 diagnostic test, named after one of India’s most famous fictitious detectives 'FELUDA', recently received ...
New Delhi: There is a recommendation to grant permission to the Serum Institute of India (SII) to conduct the second ...
New Delhi: India’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis, for “restricted emergency use” ...
New Delhi: Even as COVID-19 cases are soaring in India, patients in the country are still to get Remdesivir, an ...
© 2024 Frontmedia